Metabolic activation of the human carcinogen 1,3-butadiene (BD) by cytochrome 450 monooxygenases gives rise to a genotoxic diepoxide, 1,2,3,4-diepoxybutane (DEB). This reactive electrophile alkylates guanine bases in DNA to produce N7-(2-hydroxy-3,4-epoxy-1-yl)-dG (N7-DE-dG) adducts. Because of the positive charge at the N7 position of the purine heterocycle, N7-DEB-dG adducts are inherently unstable and can undergo spontaneous depurination or base-catalyzed imidazole ring opening to give N6-[2-deoxy-D-erythro-pentofuranosyl]-2,6-diamino-3,4-dihydro-4-oxo-5-N-1-(oxiran-2-yl)propan-1-ol-formamidopyrimidine (DEB-FAPy-dG) adducts. Here we report the first synthesis and structural characterization of DEB-FAPy-dG adducts. Authentic standards of DEB-FAPy-dG and its 15N3-labeled analogue were used for the development of a quantitative nanoLC-ESI+-HRMS/MS method, allowing for adduct detection in DEB-treated calf thymus DNA. DEB-FAPy-dG formation in DNA was dependent on DEB concentration and pH, with higher numbers observed under alkaline conditions.
|Original language||English (US)|
|Journal||Chemistry - A European Journal|
|State||Published - Jan 13 2022|
Bibliographical noteFunding Information:
We thank Yingchun Zhao for his help with MS analysis and Luke Erber for accurate mass measurements. We also thank Robert Carlson (University of Minnesota) for preparing the graphics for this manuscript. This research is supported by a grant from the National Cancer Institute (R01 CA‐100670).
© 2021 Wiley-VCH GmbH
PubMed: MeSH publication types
- Journal Article